Several rodent and cell line studies have shown that estrogen-activated signaling through estrogen receptor alpha and/or estrogen receptor beta exhibits growth inhibition effects on colon cancer cells and loss of either receptors has been detected in colorectal cancer [34-38]. Here, ESR1 is linked to colonic neoplasm.